54. Vakil N, van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of

gastroesophageal reflux disease; a global evidence-based consensus. Am J Gastroenterol

2006;101:1900–1920.

55. Locke GR, Talley NJ, Fett SL, et al. Prevalence and clinical spectrum of gastroesophageal reflux; a

population-based study in Olmsted County Minnesota. Gastroenterology 1997;112:1448.

56. Isolauri J, Laippala P. Prevalence of symptoms suggestive of gastroesophageal reflux disease in an

adult population. Ann Med 1995;27:67–70.

57. Sharma P, Wani S, Romero Y, et al. Racial and geographic issues in gastroesophageal reflux disease.

Am J Gastroenterol 2008;103:2669–2680.

58. El-Serag H. Time trends of gastroesophageal reflux disease: a systematic review. Clin Gastroenterol

Hepatol 2007;5:17–26.

59. Agency for Healthcare Research and Quality. Hospitalizations for problems caused by severe acid

reflux increase by 103 percent. AHRQ News and Numbers. Rockville, MD: Agency for Healthcare

Research and Quality; 2008. Available at: http://www.ahrq.gov/news/nn/nn010208.htm. Accessed

January, 2009.

60. El-Serag HB, Sonnenberg A. Opposing time trends of peptic ulcer and reflux disease. Gut

1998;43:327–333.

61. Panos MZ, Walt RP, Stevenson C, et al. Rising death rate from non-malignant disease of the

oesophagus (NMOD) in England and Wales. Gut 1995;36:488–491.

62. Jacobson BC, Somers SC, Fuchs CS, et al. Body-mass index and symptoms of gastroesophageal

reflux in women. N Eng J Med 2006;354:2340–2348.

63. Corely DA, Kubo A. Body mass index and gastroesophageal reflux disease: a systematic review and

meta-analysis. Am J Gastroenterol 2006;108: 2619–2628.

64. Pandolfino JE, El-Serag HB, Zhang Q, et al. Obesity: a challenge to esophagogastric junction

integrity. Gastroenterology 2006;130:639–649.

65. Edlestein ZR, Farrow DC, Bronner MP, et al. Central obesity and risk of Barrett’s esophagus.

Gastroenterology 2007;133:403–411.

66. Konturek JW. Discovery by Jaworski of Helicobacter pylori and its pathogenetic role in peptic

ulcer, gastritis and gastric cancer. J Physiol Pharmacol 2003;54(suppl 3):23–41.

67. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and

peptic ulceration. Lancet 1984;1:1311–1315.

68. Labenz J, Blum AL, Bayerdorffer E, et al. Curing Helicobacter pylori infection in patients with

duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997;112:1442–1447.

69. Bowrey DJ, Williams GT, Clark GW. Interactions between Helicobacter pylori and gastroesophageal

reflux disease. Dis Esophagus 1998;11: 203–209.

70. Werdmuller BF, Loffeld RJ. Helicobacter pylori infection has no role in the pathogenesis of reflux

esophagitis. Dig Dis Sci 1997;42:103–105.

1098

71. Loffeld RJ, Ten Tije BJ, Arends JW. Prevalence and significance of Helicobacter pylori in patients

with Barrett’s esophagus. Am J Gastroenterol 1992;87:1598–1600.

72. Weel JF, Van Der Hulst RW, Gerrits Y, et al. The interrelationship between cytotoxin-associated

gene A, vacuolating cytotoxin, and Helicobacter pylori-related diseases. J Infect Dis 1996;173:1171–

1175.

73. Vicari JJ, Peek RM, Falk GW, et al. The seroprevalence of cagA-positive Helicobacter pylori strains

in the spectrum of gastroesophageal reflux disease. Gastroenterology 1998;115:50–57.

74. Chow WH, Blaser MJ, Blot WJ, et al. An inverse relation between cagA− strains of Helicobacter

pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res 1998;58:588–

590.

75. Labenz J, Nocon M, Lind T, et al. Prospective follow-up data for the ProGERD study suggest that

GERD is not a categorical disease. Am J Gastroenterol 2006;101:2457–2462.

76. Malfertheiner P, Nocon M, Vieth M, et al. Evolution of gastro-oesophageal reflux disease over 5

years under routine medical care – the ProGERD study. Aliment Pharmacol Ther 2012;35:154–164.

77. Monnier P, Ollyo JB, Fontolliet C, et al. Epidemiology and natural history of reflux esophagitis.

Semin Laparosc Surg 1995;2:2–9.

78. Costantini M, Crookes PF, Bremner RM, et al. The value of physiologic assessment of foregut

symptoms in a surgical practice. Surgery 1993; 114:780–786; discussion 786–787.

79. Dodds WJ, Dent J, Hogan WJ, et al. Mechanisms of gastroesophageal reflux in patients with reflux

esophagitis. N Engl J Med 1982;307: 1547–1552.

80. Mittal RK, Holloway R, Dent J. Effect of atropine on the frequency of reflux and transient lower

esophageal sphincter relaxation in normal subjects. Gastroenterology 1995;109:1547–1554.

81. Mittal RK, Hollaway RH, Penagini R, et al. Transient lower esophageal sphincter relaxation.

Gastroenterology 1995;109:601–610.

82. Van Herwaarden MA, Samson M, Smout AJ. Excess gastroesophageal reflux in patients with hiatal

hernia is caused by mechanisms other than transient LES relaxations. Gastroenterology

2000;119:1439–1446.

83. Zaninotto G, DeMeester TR, Schwizer W, et al. The lower esophageal sphincter in health and

disease. Am J Surg 1988;155:104–111.

84. Stein HJ, Eypasch EP, DeMeester TR, et al. Circadian esophageal motor function in patients with

gastroesophageal reflux disease. Surgery 1990; 108:769.

85. Cohen S, Harris LD. Does hiatus hernia affect competence of the gastroesophageal sphincter. N Engl

J Med 1971;284:1053–1056.

86. Mittal RK, Fisher MJ. Electrical and mechanical inhibition of the crural diaphragm during transient

relaxation of the lower esophageal sphincter. Gastroenterology 1990;99:1265–1268.

87. Hill LD, Kozarek RA, Kraemer SJM, et al. The gastroesophageal flap valve: in vitro and in vivo

observations. Gastrointest Endosc 1996;44:541–547.

88. Kahrilas PJ, Wu S, Shezhang L, et al. Attenuation of esophageal shortening during peristalsis with

hiatus hernia. Gastroenterology 1995;109:1818–1825.

89. Fletcher J, Wirz A, Henry E, et al. Studies of acid exposure immediately above the

gastroesophageal squamocolumnar junction: evidence of short segment reflux. Gut 2004;53:168–

173.

90. Iljima K, Henry E, Moriya A, et al. Dietary nitrate generates potentially mutagenic concentrations

of nitric oxide at the gastroesophageal junction. Gastroenterology 2002;122:1248–1257.

91. Lillimoe KD, Johnson LF, Harmon JW. Role of the components of the gastroduodenal contents in

experimental acid esophagitis. Surgery 1982;92:276–284.

92. Lillimoe KD, Johnson LF, Harmon JW. Alkaline esophagitis: a comparison of the ability of

components of gastroduodenal contents to injure the rabbit esophagus. Gastroenterology

1983;85:621–628.

93. Kauer WK, Peters JH, DeMeester TR, et al. Mixed reflux of gastric juice is more harmful to the

esophagus than gastric juice alone. The need for surgical therapy reemphasized. Ann Surg

1995;222:525–533.

94. El-Serag HB, Sonnenberg A. Comorbid occurrence of laryngeal or pulmonary disease with

esophagitis in United States Military Veterans. Gastroenterology 1997;113:755–760.

1099

95. Havemann BD, Henderson CA, El-Serag HB. The association between gastro-oesophageal reflux

disease and asthma: a systematic review. Gut 2007;56:1654–1664.

96. Sontag SJ. The spectrum of pulmonary symptoms due to gastroesophageal reflux. Thorac Surg Clin

2005;15:353–368.

97. Blondeau K, Dupont L, Mertens V, et al. Gastroesophageal reflux and aspiration of gastric contents

in adult patients with cystic fibrosis. Gut 2008;57:1049–1055.

98. Rascon-Aguilar IE, Pamer M, Wludyka P, et al. Role of gastroesophageal reflux symptoms in

exacerbations of COPD. Chest 2006;130:1096–1101.

99. Hamelberg W, Bosomworth PP. Aspiration pneumonitis: experimental studies and clinical

observations. Anesth Analg Curr Res 1964;170:74–86.

100. Greenfield LJ, Singleton RP, McCaffree DR, et al. Pulmonary effects of experimental graded

aspiration of hydrochloric acid. Ann Surg 1969; 170:74–86.

101. Glauser FL, Millen JE, Falls R. Effects of acid aspiration on pulmonary alveolar epithelial

membrane permeability. Chest 1979;76:201–205.

102. Tuchman DN, Boyle JT, Pack AI, et al. Comparison of airway responses following tracheal or

esophageal acidification in the cat. Gastroenterology 1984;87:872–881.

103. Pearson JE, Wilson RS. Diffuse pulmonary fibrosis and hiatus hernia. Thorax 1971;26:300–305.

104. Mays EE, Dubois JJ, Hamilton GB. Pulmonary fibrosis associated with tracheobronchial aspiration:

a study of the frequency of hiatal hernia and gastroesophageal reflux in interstitial fibrosis of

obscure etiology. Chest 1976;69:512–515.

105. Raiha I, Manner R, Hietanen E. Radiographic pulmonary changes of gastro-oesophageal reflux

disease in elderly patients. Age Ageing 1992;21:250–255.

106. Tobin RW, Pope CE, Pellegrini CA. Increased prevalence of gastroesophageal reflux in patients with

idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1988;158:1804–1808.

107. Kauer WK, Stein HJ, Möbius C, et al. Assessment of respiratory symptoms with dual pH monitoring

in patients with gastro-oesophageal reflux disease. Br J Surg 2004;91:867–871.

108. Raghu G, Freudenberger TD, Yang S, et al. High prevalence of abnormal acid gastro-oesophageal

reflux in idiopathic pulmonary fibrosis. Eur Respir J 2006;27:136–142.

109. Crowell MD, Zayat EN, Lacy BE, et al. The effects of an inhaled beta(2)-adrenergic agonist on

lower esophageal function: a dose-response study. Chest 2001;120:1184–1189.

110. Mansfield LE, Hameister HH, Spaulding HS, et al. The role of the vagus nerve in airway narrowing

caused by intraesophageal hydrochloric acid provocation and esophageal distention. Ann Allergy

1981;47:431–434.

111. Wright RA, Miller SA, Corsello BF. Acid-induced esophagobronchial-cardiac reflexes in humans.

Gastroenterology 1990;99:71–73.

112. Schan CA, Harding SM, Haile JM, et al. Gastroesophageal reflux-induced bronchoconstriction. An

intraesophageal acid infusion study using state-of-the-art technology. Chest 1994;106:731–737.

113. Sweet MP, Patti MG, Leard LE, et al. Gastroesophageal reflux in patients with idiopathic pulmonary

fibrosis referred for lung transplantation. J Thorac Cardiovasc Surg 2007;133:1078–1084.

114. Sweet MP, Herbella FA, Leard L, et al. The prevalence of distal and proximal gastroesophageal

reflux in patients awaiting lung transplantation. Ann Surg 2006;244:491–497.

115. D’Ovidio F, Singer LG, Hadjiliadis D, et al. Prevalence of gastroesophageal reflux in end-stage lung

disease candidates for lung transplant. Ann Thoracic Surg 2005;80:1254–1261.

116. Ayazi S, Hagen JA, Zehetner J, et al. Loss of alkalization in proximal esophagus: a new diagnostic

paradigm for patients with laryngopharyngeal reflux. J Gastrointest Surg 2010;14(11):1653–1659

117. Worrell SG, DeMeester SR, Greene CL, et al. Pharyngeal pH monitoring better predicts a successful

outcome for extraesophageal reflux symptoms after antireflux surgery. Surg Endosc

2013;27(11):4113–4118.

118. Frank L, Kleinman L, Ganoczy D, et al. Upper gastrointestinal symptoms in North America:

prevalence and relationship to healthcare utilization and quality of life. Dig Dis Sci 2000;45:809–

818.

119. Jailawala JA, Shaker R. Oral and pharyngeal complications of gastroesophageal reflux disease:

globus, dental erosions, and chronic sinusitis. J Clin Gastroenterol 2000;30(3 suppl):S35–S38.

1100